← Back to all signals
LLY · Q3 2026

Eli Lilly and Company

Reported 2026-08-05
IN-LINE
51EarnIQ signal

Confidence rising

Mild quarter-over-quarter shift

Strong volume-driven revenue growth and advanced pipeline milestones demonstrate sustained momentum and robust execution.

  • Guidance was raised, with high specificity.
  • Management tone registered as confident (90/100).
  • EarnIQ detected 0 potential management deflections.
Headline–confidence gap

Mixed evidence

The headline and management signals do not point in one direction (confidence rising).

EPS: reported vs expected+38.1%$8.38 vs $6.07
Revenue: reported vs expected+9.8%$23.0B vs $20.9B
Guidance specificityHighRaised
Market expectations supplied by Finnhub · Reported vs consensus estimate

Lilly's momentum continues, as we delivered 48% revenue growth and raised our full-year guidance.

EarnIQ Premium

Understand exactly why confidence changed.

Unlock management-language evidence, guidance specificity, the pressure point, narrative breaks, risks, and quarter-over-quarter topic changes.

Guidance specificityPressure pointNarrative breakSource evidence
Preview full report